Fmoc-S-tert.butyl-L-cysteine

Fmoc-S-tert.butyl-L-cysteine is an Fmoc-protected L-cysteine derivative in which the thiol side chain is masked as an S-tert-butyl thioether, preserving the amino acid's chiral center while providing a stable, orthogonally removable sulfur protecting group. The molecule contains an N-(9H-fluoren-9-ylmethoxycarbonyl) carbamate for base-stable N-protection, a free carboxylate functionality as part of the amino acid scaffold, and a tert-butyl thioether that can be selectively deprotected under conditions compatible with peptide synthesis. The combination of an Fmoc group and a thioether sulfur protecting strategy supports controlled peptide coupling at the amino acid level while enabling downstream side-chain functionalization through thiol regeneration. The resulting reactivity profile aligns with peptide building block preparation, cysteine-containing sequence assembly, and sulfur-based derivatization chemistry used for structure and function studies.

1. Peptide Synthesis

Fmoc-S-tert.butyl-L-cysteine is applied in solid-phase peptide synthesis and related peptide building block workflows where N-Fmoc protection and side-chain sulfur masking are required for chemoselective coupling. The Fmoc carbamate enables iterative deprotection cycles under base, while the S-tert-butyl thioether protects the cysteine thiol from undesired oxidation, disulfide scrambling, and side reactions during chain assembly. The amino acid backbone supports standard amide bond formation at the carboxylate/amine interface, and the protected sulfur can be carried through synthesis until the desired stage of thiol unveiling. The compound therefore functions as a practical cysteine-containing residue precursor for peptide analog construction, including sequences that later undergo controlled thiol-mediated conjugation or disulfide formation.

2. Side-Chain Functionalization

Fmoc-S-tert.butyl-L-cysteine supports side-chain functionalization strategies in synthetic organic chemistry and chemical biology where cysteine sulfur chemistry is used as a handle for selective modification. The masked thiol can be converted to a reactive thiol under appropriate deprotection conditions, enabling formation of thioethers, thioesters, disulfide bonds, or thiol-electrophile conjugates depending on the electrophile partner. The preserved stereochemistry of the L-cysteine scaffold helps maintain defined spatial orientation for sulfur reactivity in downstream derivatives, which is relevant for molecular recognition studies and peptide-based probes. The Fmoc-protected N-terminus and carboxyl functionality also allow incorporation into larger constructs before sulfur activation, supporting stepwise synthesis of functionalized amino acid derivatives and peptide conjugates.

3. Bioconjugation Chemistry

Fmoc-S-tert.butyl-L-cysteine is used in bioconjugation and biomolecule modification programs where cysteine thiol functionality enables controlled attachment of labels, linkers, or affinity tags. The S-tert-butyl thioether provides protection during synthetic handling and can be unmasked to generate a thiol suitable for conjugation chemistries that require site-defined sulfur reactivity. The Fmoc-protected amino acid form can be incorporated into peptide carriers or peptide-based linkers prior to thiol activation, supporting conjugation workflows that need both peptide compatibility and selective sulfur coupling. The resulting derivatives can serve as intermediates for labeled peptides, cysteine-reactive probes, and modular conjugation components used to interrogate biomolecular interactions.

4. Peptidomimetics And SAR Studies

Fmoc-S-tert.butyl-L-cysteine is applicable to peptidomimetic construction and structure-activity relationship studies where cysteine residues are incorporated as stereodefined functional elements within bioactive scaffolds. The protected amine and sulfur allow the building of analog libraries through sequential coupling while minimizing thiol oxidation and side reactions that can complicate SAR synthesis. The chiral L-cysteine center contributes defined geometry for sulfur-bearing pharmacophore placement, and the protected thiol can be converted into alternative sulfur oxidation states or connectivity patterns to probe structure-function relationships. The compound thereby serves as an amino acid intermediate enabling controlled generation of cysteine-containing analogs for medicinal chemistry research and related scaffold optimization campaigns.

5. Pharmaceutical Intermediate Preparation

Fmoc-S-tert.butyl-L-cysteine is suitable for pharmaceutical intermediate preparation in fine chemical manufacturing contexts that require protected amino acid building blocks compatible with peptide-derived active ingredient synthesis. The Fmoc group supports robust N-protection during synthetic steps and can be removed under base conditions commonly used in peptide chemistry, while the S-tert-butyl thioether provides a stable sulfur-protection approach that reduces process-related thiol degradation. The amino acid scaffold can be integrated into larger protected sequences or used to prepare cysteine-containing intermediates that later undergo thiol unmasking and controlled coupling. The compound's protection strategy aligns with industrially relevant planning for downstream deprotection, conjugation, and controlled formation of sulfur-containing motifs used in peptide and peptide-like manufacturing routes.

1. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

2. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

3. TMEM16F and dynamins control expansive plasma membrane reservoirs

4. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

5. Emu oil in combination with other active ingredients for treating skin imperfections